Cardio-Oncologists manage heart health in patients undergoing cancer treatment. Many cancer treatments, such as chemotherapy and radiation, can have side effects that impact the heart, potentially leading to conditions like heart failure, arrhythmias, and other cardiovascular complications. Cardio-oncologists assess the heart's function before, during, and after cancer treatment to detect any changes and mitigate potential risks. They use specialized diagnostic tools, including echocardiograms, electrocardiograms (ECGs), and advanced imaging techniques, to monitor the heart’s health and ensure it remains stable throughout cancer therapy.
These professionals work closely with oncologists, cardiologists, and other healthcare providers to create a comprehensive care plan that addresses both cancer treatment and cardiovascular health. They help patients understand how cancer treatments can affect their heart and provide strategies to minimize damage, such as adjusting medications or incorporating heart-healthy practices. Cardio-oncologists also provide ongoing care for survivors, addressing any heart conditions that may develop after treatment and ensuring that patients maintain optimal cardiovascular health throughout their lives. With their expertise, cardio-oncologists ensure that cancer treatments are effective without compromising heart health. They help patients navigate the delicate balance between cancer recovery and heart care, ensuring both are managed effectively. By prioritizing both cardiac and oncological care, they provide a well-rounded approach to cancer recovery and long-term health.
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation